50 mg Proellex

DRUG2 trials

Sponsors

Repros Therapeutics Inc.

Conditions

HealthyRenal Impairment

Phase 1

Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females

TerminatedNCT00787618

Repros Therapeutics Inc.Renal Impairment

Start: 2008-10-31End: 2009-07-31Updated: 2014-08-25

Proellex Pharmacokinetics Bridging Study

CompletedNCT01067807

Repros Therapeutics Inc.Healthy

Start: 2007-06-30End: 2007-07-31Updated: 2014-07-08